Mario Mandala

220 posts

Mario Mandala

Mario Mandala

@MandalaMario

Associate professor of Medical Oncology

University of Perugia Katılım Aralık 2012
288 Takip Edilen288 Takipçiler
Mario Mandala retweetledi
Via Medica
Via Medica@ViaMedica_pl·
📢 „Advances in diagnostics and therapy of melanoma and other skin cancers” 📅 19 marca i 14 maja 2026 Zapraszają: prof. dr hab. n. med. Piotr Rutkowski, prof. Mario Mandalà 🤝 Patronat: Akademia Czerniaka, IMI Bezpłatna rejestracja: melanoma.viamedica.pl #melanoma #oncology
Via Medica tweet media
Polski
1
3
4
216
Mario Mandala
Mario Mandala@MandalaMario·
Super interesting, interactive, outstanding meeting on rare toxicities in patients receiving Immunotherapy A special thant to @DrJNaidoo Jarushka Naidoo for charing the session Thanks @myESMO for organising such beautiful and engaging meeting
Mario Mandala tweet mediaMario Mandala tweet mediaMario Mandala tweet media
English
0
0
2
205
Mario Mandala
Mario Mandala@MandalaMario·
Immunotherapy or targeted therapy with or without stereotactic radiosurgery for patients with brain metastases from melanoma or non-small cell lung cancer - The ETOP 19-21 USZ-STRIKE study - PubMed pubmed.ncbi.nlm.nih.gov/39731865/
English
0
0
0
32
Mario Mandala
Mario Mandala@MandalaMario·
Clinical validation of droplet digital PCR assays in detecting BRAFV600-mutant circulating tumour DNA as a prognostic biomarker in patients with resected stage III melanoma receiving adjuvant therapy (COMBI-AD): a biomarker analysis from a randomised study pubmed.ncbi.nlm.nih.gov/40250457/
English
0
0
0
31
Mario Mandala
Mario Mandala@MandalaMario·
Combined immunotherapy with nivolumab and ipilimumab with and without sequential or concomitant stereotactic radiotherapy in patients with melanoma brain metastasis: an international retrospective study - European Journal of Cancer ejcancer.com/article/S0959-…
English
1
1
3
251
Professor Georgina Long AO (Bluesky @gvlongphdmd)
It was a momentous time celebrating @ausoftheyear 2025 with my daughters (one watching proudly from the USA!), my rock of a husband, and my wise brilliant mum. As I welcome our inspiring new awardees, I reflect on an incredible 2024: pioneering melanoma research that transformed clinical practice, leading groundbreaking discoveries with brilliant women scientists & clinicians, and exploring our vast nation's changemakers. Through the highs of #research success and raising awareness for #SunSafety (preventing melanoma - Australia's cancer), came profound loss - farewell to my beloved father Geoff Long, whose wisdom & cut-through I miss daily. Grateful for my 5 siblings, mum, and family who carry his legacy forward. Thank you Australia for a truly unforgettable year. @Sydney_Uni @MelanomaAus @Science_Academy @abcnews @ABCTV @gg_sammostyn @AlboMP @PatrickGormanMP @ProfRAScolyer @FightMND @KatrinaWruck youtu.be/VfJKuE114Do?fe…
YouTube video
YouTube
Professor Georgina Long AO (Bluesky @gvlongphdmd) tweet mediaProfessor Georgina Long AO (Bluesky @gvlongphdmd) tweet mediaProfessor Georgina Long AO (Bluesky @gvlongphdmd) tweet mediaProfessor Georgina Long AO (Bluesky @gvlongphdmd) tweet media
English
5
6
127
3.1K
Mario Mandala
Mario Mandala@MandalaMario·
@EdWilli63968626 Difficult studies to carry out, most of them academic trials but the only way to understand the best sequence and the role of each treatment IO and RT
English
1
0
1
16
Ed Williams
Ed Williams@EdWilli63968626·
@MandalaMario I have been following ABC-x out of Australia and it has been years with no published results, I wonder if they are having the same issue of getting patients to volunteer for this trial? I had SRS cyberknife treatment in 2013 for 3 small 4-5mm melanoma brain mets successfully.
English
1
0
0
46
Mario Mandala
Mario Mandala@MandalaMario·
Understanding timing of SRS and immunotherapy: the right study for the right question in patients with brain metastases from melanoma or non-small cell lung cancer – The ETOP 19-21 USZ-STRIKE study - Lung Cancer lungcancerjournal.info/article/S0169-…
English
2
2
10
405
Mario Mandala
Mario Mandala@MandalaMario·
Adjuvant pembrolizumab did not have a significant impact on long-term HRQOL compared with placebo in patients with resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): long-term, health-related quality-of-life results thelancet.com/journals/lanon…
English
1
0
2
131